Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02 Februar 2024 - 10:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities
Exchange Act of 1934
(Amendment No. 2)*
Enliven Therapeutics, Inc.
(Name
of Issuer)
Common Stock, par value
$0.001 per share
(Title
of Class of Securities)
29337E102
(CUSIP
Number)
5AM Venture Management,
LLC
Attn: Paul A. Stone,
Chief Legal Officer
501 2nd Street, Suite 350
San Francisco, CA 94107
(415) 993-8565
(Name,
Address and Telephone Number of Person
Authorized to Receive Notices
and Communications)
January 31, 2024
(Date
of Event Which Requires Filing of this Statement)
If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D,
and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨
Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7
for other parties to whom copies are to be sent.
* The remainder of this cover page shall
be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder
of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act
of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
CUSIP
No. 29337E102 |
1. |
Names of Reporting Persons
5AM Ventures VI, L.P. |
2. |
Check
the Appropriate Box if a Member of a Group (See Instructions) |
|
(a) ¨
(b) x (1) |
3. |
SEC
Use Only |
4. |
Source of Funds (See Instructions)
WC |
5. |
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨ |
6. |
Citizenship or Place of Organization
Delaware |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
7. |
Sole Voting Power
0 |
8. |
Shared Voting Power
3,888,992 shares (2) |
9. |
Sole Dispositive Power
0 |
10. |
Shared Dispositive Power
3,888,992 shares (2) |
11. |
Aggregate Amount Beneficially Owned by Each Reporting Person
3,888,992 shares (2) |
12. |
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨ |
13. |
Percent of Class Represented by Amount in Row (11)
9.4% (3) |
14. |
Type of Reporting Person (See Instructions)
PN |
|
|
|
|
(1) | This Schedule 13D is filed by 5AM Ventures VI, L.P. (“Ventures
VI”), 5AM Partners VI, LLC (“Partners VI”), 5AM Opportunities I, L.P. (“Opportunities”),
5AM Opportunities I (GP), LLC (“Opportunities GP”), Andrew J. Schwab (“Schwab”)
and Dr. Kush Parmar (“Parmar” and, with Ventures VI, Partners VI, Opportunities, Opportunities
GP and Schwab, collectively, the “Reporting Persons”). The Reporting Persons expressly
disclaim status as a “group” for purposes of this Schedule 13D. |
(2) | The shares are directly held by Ventures VI. Partners VI serves as
sole general partner of Ventures VI and Schwab and Parmar are managing members of Partners VI. Each
of Partners VI, Schwab and Parmar shares voting and dispositive power over the shares held by Ventures
VI. |
(3) | This percentage is calculated based upon 41,211,973 shares of Common Stock outstanding as of November 1, 2023, as reported in the Issuer’s
Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the Securities and Exchange Commission on November
9, 2023. |
CUSIP
No. 29337E102 |
1. |
Names of Reporting Persons
5AM Partners VI, LLC |
2. |
Check
the Appropriate Box if a Member of a Group (See Instructions) |
|
(a) ¨
(b) x (1) |
3. |
SEC
Use Only |
4. |
Source of Funds (See Instructions)
AF |
5. |
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨ |
6. |
Citizenship or Place of Organization
Delaware |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
7. |
Sole Voting Power
0 |
8. |
Shared Voting Power
3,888,992 shares (2) |
9. |
Sole Dispositive Power
0 |
10. |
Shared Dispositive Power
3,888,992 shares (2) |
11. |
Aggregate Amount Beneficially Owned by Each Reporting Person
3,888,992 shares (2) |
12. |
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨ |
13. |
Percent of Class Represented by Amount in Row (11)
9.4% (3) |
14. |
Type of Reporting Person (See Instructions)
OO |
|
|
|
|
(1) | This Schedule 13D is filed by the Reporting Persons. The Reporting
Persons expressly disclaim status as a “group” for purposes of this Schedule 13D. |
(2) | The shares are directly held by Ventures VI. Partners VI serves as
sole general partner of Ventures VI and Schwab and Parmar are managing members of Partners VI. Each
of Partners VI, Schwab and Parmar shares voting and dispositive power over the shares held by Ventures
VI. |
(3) | This percentage is calculated based upon 41,211,973 shares of Common Stock outstanding as of November 1, 2023, as reported in the Issuer’s
Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the Securities and Exchange Commission on November
9, 2023. |
CUSIP
No. 29337E102 |
1. |
Names of Reporting Persons
5AM Opportunities I, L.P. |
2. |
Check
the Appropriate Box if a Member of a Group (See Instructions) |
|
(a) ¨
(b) x (1) |
3. |
SEC
Use Only |
4. |
Source of Funds (See Instructions)
WC |
5. |
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨ |
6. |
Citizenship or Place of Organization
Delaware |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
7. |
Sole Voting Power
0 |
8. |
Shared Voting Power
771,983 shares (2) |
9. |
Sole Dispositive Power
0 |
10. |
Shared Dispositive Power
771,983 shares (2) |
11. |
Aggregate Amount Beneficially Owned by Each Reporting Person
771,983 shares (2) |
12. |
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨ |
13. |
Percent of Class Represented by Amount in Row (11)
1.9% (3) |
14. |
Type of Reporting Person (See Instructions)
PN |
|
|
|
|
(1) | This Schedule 13D is filed by the Reporting Persons. The Reporting
Persons expressly disclaim status as a “group” for purposes of this Schedule 13D. |
(2) | The shares are directly held by Opportunities. Opportunities GP serves
as sole general partner of Opportunities and Schwab and Parmar are managing members of Opportunities
GP. Each of Opportunities GP, Schwab and Parmar shares voting and dispositive power over the shares
held by Opportunities. |
(3) | This percentage is calculated based upon 41,211,973 shares of Common Stock outstanding as of November 1, 2023, as reported in the Issuer’s
Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the Securities and Exchange Commission on November
9, 2023. |
CUSIP
No. 29337E102 |
1. |
Names of Reporting Persons
5AM Opportunities I (GP), LLC |
2. |
Check
the Appropriate Box if a Member of a Group (See Instructions) |
|
(a) ¨
(b) x (1) |
3. |
SEC
Use Only |
4. |
Source of Funds (See Instructions)
AF |
5. |
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨ |
6. |
Citizenship or Place of Organization
Delaware |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
7. |
Sole Voting Power
0 |
8. |
Shared Voting Power
771,983 shares (2) |
9. |
Sole Dispositive Power
0 |
10. |
Shared Dispositive Power
771,983 shares (2) |
11. |
Aggregate Amount Beneficially Owned by Each Reporting Person
771,983 shares (2) |
12. |
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨ |
13. |
Percent of Class Represented by Amount in Row (11)
1.9% (3) |
14. |
Type of Reporting Person (See Instructions)
OO |
|
|
|
|
(1) | This Schedule 13D is filed by the Reporting Persons. The Reporting
Persons expressly disclaim status as a “group” for purposes of this Schedule 13D. |
(2) | The shares are directly held by Opportunities. Opportunities GP serves
as sole general partner of Opportunities and Schwab and Parmar are managing members of Opportunities
GP. Each of Opportunities GP, Schwab and Parmar shares voting and dispositive power over the shares
held by Opportunities. |
(3) | This percentage is calculated based upon 41,211,973 shares of Common Stock outstanding as of November 1, 2023, as reported in the Issuer’s
Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the Securities and Exchange Commission on November
9, 2023. |
CUSIP
No. 29337E102 |
1. |
Names of Reporting Persons
Kush Parmar |
2. |
Check
the Appropriate Box if a Member of a Group (See Instructions) |
|
(a) ¨
(b) x (1) |
3. |
SEC
Use Only |
4. |
Source of Funds (See Instructions)
AF |
5. |
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨ |
6. |
Citizenship or Place of Organization
United States |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
7. |
Sole Voting Power
0 |
8. |
Shared Voting Power
4,660,975 shares (2) |
9. |
Sole Dispositive Power
0 |
10. |
Shared Dispositive Power
4,660,975 shares (2) |
11. |
Aggregate Amount Beneficially Owned by Each Reporting Person
4,660,975 shares (2) |
12. |
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨ |
13. |
Percent of Class Represented by Amount in Row (11)
11.3% (3) |
14. |
Type of Reporting Person (See Instructions)
IN |
|
|
|
|
(1) | This Schedule 13D is filed by the Reporting Persons. The Reporting
Persons expressly disclaim status as a “group” for purposes of this Schedule 13D. |
(2) | Includes (i) 3,888,992 shares of Common Stock held by Ventures
VI and (ii) 771,983 shares of Common Stock held by Opportunities. Partners VI serves as the sole
general partner of Ventures VI and Opportunities GP serves as the sole general partner of Opportunities.
As managing members of each of Partners VI and Opportunities GP, Schwab and Parmar share voting and
dispositive power over the shares held by each of Ventures VI and Opportunities. |
(3) | This percentage is calculated based upon 41,211,973 shares of Common Stock outstanding as of November 1, 2023, as reported in the Issuer’s
Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the Securities and Exchange Commission on November
9, 2023. |
CUSIP
No. 29337E102 |
1. |
Names of Reporting Persons
Andrew J. Schwab |
2. |
Check
the Appropriate Box if a Member of a Group (See Instructions) |
|
(a) ¨
(b) x (1) |
3. |
SEC
Use Only |
4. |
Source of Funds (See Instructions)
AF |
5. |
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨ |
6. |
Citizenship or Place of Organization
United States |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
7. |
Sole Voting Power
0 |
8. |
Shared Voting Power
4,660,975 shares (2) |
9. |
Sole Dispositive Power
0 |
10. |
Shared Dispositive Power
4,660,975 shares (2) |
11. |
Aggregate Amount Beneficially Owned by Each Reporting Person
4,660,975 shares (2) |
12. |
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨ |
13. |
Percent of Class Represented by Amount in Row (11)
11.3% (3) |
14. |
Type of Reporting Person (See Instructions)
IN |
|
|
|
|
(1) | This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes
of this Schedule 13D. |
(2) | Includes (i) 3,888,992 shares of Common Stock held by Ventures VI and (ii) 771,983 shares of Common Stock held by Opportunities. Partners
VI serves as the sole general partner of Ventures VI and Opportunities GP serves as the sole general partner of Opportunities. As managing
members of each of Partners VI and Opportunities GP, Schwab and Parmar share voting and dispositive power over the shares held by each
of Ventures VI and Opportunities. |
(3) | This percentage is calculated based upon 41,211,973 shares of Common Stock outstanding as of November 1, 2023, as reported in the Issuer’s
Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the Securities and Exchange Commission on November
9, 2023. |
Explanatory Note: This
Amendment No. 2 (the “Amendment”), which amends the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”)
on March 6, 2023, as amended on August 28, 2023 (the “Original Schedule 13D”) on behalf of 5AM Ventures VI, L.P. (“Ventures
VI”), 5AM Partners VI, LLC (“Partners VI”), 5AM Opportunities I, L.P. (“Opportunities”), 5AM Opportunities
I (GP), LLC (“Opportunities GP”), Andrew J. Schwab (“Schwab”) and Dr. Kush Parmar (“Parmar” and, with
Ventures VI, Partners VI, Opportunities, Opportunities GP and Schwab, collectively, the “Reporting Persons”) relates to the
Common Stock, par value $0.001 per share (“Common Stock”) of Enliven Therapeutics, Inc., a Delaware corporation (the “Issuer”).
This Amendment is being filed by the Reporting Persons to report sales of Common Stock on January 31, 2024. Accordingly, the number of
securities beneficially owned by the Reporting Persons has decreased as described in Items 4 and 5 below.
Items 4 and 5 of the Original Schedule 13D are
hereby amended and supplemented to the extent hereinafter expressly set forth and, except as amended and supplemented hereby, the Original
Schedule 13D remains in full force and effect. All capitalized terms used in this Amendment but not defined herein shall have the meanings
ascribed thereto in the Original Schedule 13D.
Item 4. | Purpose of Transaction |
Item 4 of the Original Schedule 13D is hereby
amended and supplemented by adding the following paragraph at the end of Item 4:
On January 31, 2024, Ventures VI sold an aggregate
of 417,187 shares of Common Stock and Opportunities sold an aggregate of 82,813 shares of Common Stock in a block trade with a registered
broker dealer at a price of $15.00 per share.
Item 5. | Interest in Securities of the
Issuer |
Item 5 of the Schedule 13D is hereby amended and restated in its
entirety as follows:
(a) – (b). |
The
following information with respect to the ownership of the Common Stock of the Issuer by the persons filing this statement on Schedule
13D is provided as of February 2, 2024: |
Reporting Persons | |
Shares
Held
Directly | | |
Sole Voting
Power | | |
Shared
Voting
Power | | |
Sole
Dispositive
Power | | |
Shared
Dispositive
Power | | |
Beneficial
Ownership | | |
Percentage
of Class (3) | |
Ventures VI | |
| 3,888,992 | | |
| 0 | | |
| 3,888,992 | | |
| 0 | | |
| 3,888,992 | | |
| 3,888,992 | | |
| 9.4 | % |
Partners VI (1) | |
| 0 | | |
| 0 | | |
| 3,888,992 | | |
| 0 | | |
| 3,888,992 | | |
| 3,888,992 | | |
| 9.4 | % |
Opportunities | |
| 771,983 | | |
| 0 | | |
| 771,983 | | |
| 0 | | |
| 771,983 | | |
| 771,983 | | |
| 1.9 | % |
Opportunities GP (2) | |
| 0 | | |
| 0 | | |
| 771,983 | | |
| 0 | | |
| 771,983 | | |
| 771,983 | | |
| 1.9 | % |
Schwab (1) (2) | |
| 0 | | |
| 0 | | |
| 4,660,975 | | |
| 0 | | |
| 4,660,975 | | |
| 4,660,975 | | |
| 11.3 | % |
Parmar (1) (2) | |
| 0 | | |
| 0 | | |
| 4,660,975 | | |
| 0 | | |
| 4,660,975 | | |
| 4,660,975 | | |
| 11.3 | % |
| (1) | Includes 3,888,992 shares of Common Stock directly held by Ventures VI. Partners VI serves as sole general
partner of Ventures VI and Schwab and Parmar are managing members of Partners VI. Each of Partners VI, Schwab and Parmar shares voting
and dispositive power over the shares held by Ventures VI. |
| (2) | Includes 771,983 shares of Common Stock directly held by Opportunities. Opportunities GP serves as sole
general partner of Opportunities and Schwab and Parmar are managing members of Opportunities GP. Each of Opportunities GP, Schwab and
Parmar shares voting and dispositive power over the shares held by Opportunities. |
| (3) | This percentage is calculated based upon (i) 41,211,973 shares of Common Stock outstanding as of November
1, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with
the Securities and Exchange Commission on November 9, 2023. |
(c) | Except as set forth herein, none of the Reporting Persons has effected any transactions in shares of the
Issuer’s Common Stock during the last 60 days. |
(d) | No other person is known to have the right to receive or the power to direct the receipt of dividends
from, or any proceeds from the sale of, the shares of Common Stock beneficially owned by any of the Reporting Persons. |
Item 7. | Material to be Filed as Exhibits |
A. | Joint Filing Agreement, dated December 13, 2021 (incorporated by reference to the Original Schedule 13D, filed on March 6, 2023). |
Signature
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 2, 2024
5AM Ventures VI, L.P. |
|
|
|
|
By: |
5AM Partners VI, LLC |
|
its |
General Partner |
|
|
|
|
By: |
/s/ Andrew J. Schwab |
|
|
Name: Andrew J. Schwab |
|
|
Title: Managing Member |
|
|
|
|
5AM Partners VI, LLC |
|
|
|
|
By: |
/s/ Andrew J. Schwab |
|
|
Name: Andrew J. Schwab |
|
|
Title: Managing Member |
|
|
|
|
5AM Opportunities I, L.P. |
|
|
|
|
By: |
5AM Opportunities I (GP), LLC |
|
its |
General Partner |
|
|
|
|
By: |
/s/ Andrew J. Schwab |
|
|
Name: Andrew J. Schwab |
|
|
Title: Managing Member |
|
|
|
|
5AM Opportunities I (GP), LLC |
|
|
|
|
By: |
/s/ Andrew J. Schwab |
|
|
Name: Andrew J. Schwab |
|
|
Title: Managing Member |
|
|
|
|
/s/ Andrew J. Schwab |
|
Andrew J. Schwab |
|
|
|
|
/s/ Dr. Kush Parmar |
|
Dr. Kush Parmar |
|
|
ATTENTION |
|
Intentional
misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001). |
Enliven Therapeutics (NASDAQ:ELVN)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Enliven Therapeutics (NASDAQ:ELVN)
Historical Stock Chart
Von Jun 2023 bis Jun 2024